Associated Papers
Novel germline and somatic variants in familial and sporadic meningioma genes.
Bencheikh BOA et al.
Npj Genomic Medicine, 2025
40374631 (PubMed )
Supplement: 41525_2025_494_MOESM2_ESM.xlsx › Sheet1
A comprehensive benchmark for multiple highly efficient base editors with broad targeting scope.
Wang X et al.
Biorxiv : the Preprint Server for Biology, 2025
39763781 (PubMed )
Supplement: media-3.xlsx › ABE_screen_library
Super-enhancer hijacking drives ectopic expression of hedgehog pathway ligands in meningiomas.
Youngblood MW et al.
Nature Communications, 2023
37805627 (PubMed )
Supplement: 41467_2023_41926_MOESM3_ESM.xlsx › SD1
NF2 Alteration/22q Loss Is Associated with Recurrence in WHO Grade 1 Sphenoid Wing Meningiomas.
Sakai Y et al.
Cancers, 2022
35804955 (PubMed )
Supplement: cancers-14-03183-s001.zip › supplementary_table_S4.xlsx › supplementary_table
Mutation Status and Epithelial Differentiation Stratify Recurrence Risk in Chordoid Meningioma-A Multicenter Study with High Prognostic Relevance.
Georgescu MM et al.
Cancers, 2020
Diffuse midline skull base meningiomas: identification of a rare and aggressive subgroup of meningiomas.
Peyre M et al.
Journal of Neuro-oncology, 2017
Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO.
Clark VE et al.
Science (new York, N.y.), 2013
Secretory meningiomas are defined by combined KLF4 K409Q and TRAF7 mutations.
Reuss DE et al.
Acta Neuropathologica, 2013
Select a paper to view details